{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T08:31:10Z","timestamp":1794990670549,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) is the consequence of neuronal death and brain atrophy associated with the aggregation of protein tau into fibrils. Thus disaggregation of tau fibrils could be a therapeutic approach to AD. The small molecule EGCG, abundant in green tea, has long been known to disaggregate tau and other amyloid fibrils, but EGCG has poor drug-like properties, failing to fully penetrate the brain. Here we have cryogenically trapped an intermediate of brain-extracted tau fibrils on the kinetic pathway to EGCG-induced disaggregation and have determined its cryoEM structure. The structure reveals that EGCG molecules stack in polar clefts between the paired helical protofilaments that pathologically define AD. Treating the EGCG binding position as a pharmacophore, we computationally screened thousands of drug-like compounds for compatibility for the pharmacophore, discovering several that experimentally disaggregate brain-derived tau fibrils in vitro. This work suggests the potential of structure-based, small-molecule drug discovery for amyloid diseases.<\/jats:p>","DOI":"10.1038\/s41467-022-32951-4","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T12:04:09Z","timestamp":1663329849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":191,"title":["Structure-based discovery of small molecules that disaggregate Alzheimer\u2019s disease tissue derived tau fibrils in vitro"],"prefix":"10.1038","volume":"13","author":[{"given":"Paul M.","family":"Seidler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4487-0230","authenticated-orcid":false,"given":"David R.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2661-8226","authenticated-orcid":false,"given":"Peng","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0874-9043","authenticated-orcid":false,"given":"Michael R.","family":"Sawaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn J.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romany","family":"Abskharon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"DeTure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7189-7917","authenticated-orcid":false,"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry V.","family":"Vinters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2432-5419","authenticated-orcid":false,"given":"David S.","family":"Eisenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"32951_CR1","doi-asserted-by":"publisher","first-page":"eaau5732","DOI":"10.1126\/scitranslmed.aau5732","volume":"12","author":"R La Joie","year":"2020","unstructured":"La Joie, R. et al. Prospective longitudinal atrophy in Alzheimer\u2019s disease correlates with the intensity and topography of baseline tau-PET. Sci. Transl. Med. 12, eaau5732 (2020).","journal-title":"Sci. Transl. Med."},{"key":"32951_CR2","doi-asserted-by":"publisher","first-page":"eabb8255","DOI":"10.1126\/science.abb8255","volume":"371","author":"C-W Chang","year":"2021","unstructured":"Chang, C.-W., Shao, E. & Mucke, L. Tau: enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies. Science 371, eabb8255 (2021).","journal-title":"Science"},{"key":"32951_CR3","doi-asserted-by":"crossref","unstructured":"Soeda, Y. & Takashima, A. New insights into drug discovery targeting tau protein. Front. Mol. Neurosci. 13, 590896 (2020).","DOI":"10.3389\/fnmol.2020.590896"},{"key":"32951_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon, E. E. & Sigurdsson, E. M. Tau-targeting therapies for Alzheimer disease. Nat. Rev. Neurol. 14, 399\u2013415 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"32951_CR5","unstructured":"LMTM. ALZFORUM. https:\/\/www.alzforum.org\/therapeutics\/lmtm (2019)."},{"key":"32951_CR6","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.phytochem.2006.06.020","volume":"67","author":"DG Nagle","year":"2006","unstructured":"Nagle, D. G., Ferreira, D. & Zhou, Y.-D. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry 67, 1849\u20131855 (2006).","journal-title":"Phytochemistry"},{"key":"32951_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-3-319-18365-7_7","volume":"863","author":"K Andrich","year":"2015","unstructured":"Andrich, K. & Bieschke, J. The effect of (-)-epigallo-catechin-(3)-gallate on amyloidogenic proteins suggests a common mechanism. Adv. Exp. Med. Biol. 863, 139\u2013161 (2015).","journal-title":"Adv. Exp. Med. Biol."},{"key":"32951_CR8","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.18632\/oncotarget.27963","volume":"12","author":"SK Sonawane","year":"2021","unstructured":"Sonawane, S. K. & Chinnathambi, S. Epigallocatechin-3-gallate modulates tau post-translational modifications and cytoskeletal network. Oncotarget 12, 1083\u20131099 (2021).","journal-title":"Oncotarget"},{"key":"32951_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69429-6","volume":"10","author":"SK Sonawane","year":"2020","unstructured":"Sonawane, S. K. et al. EGCG impedes human Tau aggregation and interacts with Tau. Sci. Rep. 10, 12579 (2020).","journal-title":"Sci. Rep."},{"key":"32951_CR10","doi-asserted-by":"crossref","unstructured":"Wobst, H. J., Sharma, A, Diamond, M. I., Wanker, E. E. & Bieschke, J. The green tea polyphenol (-)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios. FEBS Lett. 589, 77\u201383 (2015).","DOI":"10.1016\/j.febslet.2014.11.026"},{"key":"32951_CR11","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1073\/pnas.0910723107","volume":"107","author":"J Bieschke","year":"2010","unstructured":"Bieschke, J. et al. EGCG remodels mature \u03b1-synuclein and amyloid-\u03b2 fibrils and reduces cellular toxicity. Proc. Natl Acad. Sci. USA 107, 7710\u20137715 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32951_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1179\/1476830515Y.0000000038","volume":"19","author":"AS Chesser","year":"2016","unstructured":"Chesser, A. S., Ganeshan, V., Yang, J. & Johnson, G. V. W. Epigallocatechin-3-gallate enhances clearance of phosphorylated tau in primary neurons. Nutr. Neurosci. 19, 21\u201331 (2016).","journal-title":"Nutr. Neurosci."},{"key":"32951_CR13","doi-asserted-by":"publisher","first-page":"10288","DOI":"10.1128\/JVI.77.19.10288-10294.2003","volume":"77","author":"DA Kocisko","year":"2003","unstructured":"Kocisko, D. A. et al. New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J. Virol. 77, 10288 (2003).","journal-title":"J. Virol."},{"key":"32951_CR14","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/nchembio.246","volume":"5","author":"BE Roberts","year":"2009","unstructured":"Roberts, B. E. et al. A synergistic small-molecule combination directly eradicates diverse prion strain structures. Nat. Chem. Biol. 5, 936\u2013946 (2009).","journal-title":"Nat. Chem. Biol."},{"key":"32951_CR15","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez, V. A. et al. Bioavailability of epigallocatechin gallate administered with different nutritional strategies in healthy volunteers. Antioxidants 9, 440 (2020).","DOI":"10.3390\/antiox9050440"},{"key":"32951_CR16","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera, F. et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11, 909\u2013913 (2009).","journal-title":"Nat. Cell Biol."},{"key":"32951_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00401-018-1855-6","volume":"136","author":"SK Kaufman","year":"2018","unstructured":"Kaufman, S. K., Del Tredici, K., Thomas, T. L., Braak, H. & Diamond, M. I. Tau seeding activity begins in the transentorhinal\/entorhinal regions and anticipates phospho-tau pathology in Alzheimer\u2019s disease and PART. Acta Neuropathol. 136, 57\u201367 (2018).","journal-title":"Acta Neuropathol."},{"key":"32951_CR18","doi-asserted-by":"crossref","unstructured":"DeVos, S. L. et al. Synaptic tau seeding precedes tau pathology in human Alzheimer\u2019s disease brain. Front. Neurosci. 12, 267 (2018).","DOI":"10.3389\/fnins.2018.00267"},{"key":"32951_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/jnen\/nly010","volume":"77","author":"GS Gibbons","year":"2018","unstructured":"Gibbons, G. S. et al. Detection of Alzheimer disease (AD)-specific tau pathology in AD and nonAD tauopathies by immunohistochemistry with novel conformation-selective tau antibodies. J. Neuropathol. Exp. Neurol. 77, 216\u2013228 (2018).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"32951_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick, A. W. P. et al. Cryo-EM structures of tau filaments from Alzheimer\u2019s disease. Nature 547, 185\u2013190 (2017).","journal-title":"Nature"},{"key":"32951_CR21","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00401-018-1914-z","volume":"136","author":"B Falcon","year":"2018","unstructured":"Falcon, B. et al. Tau filaments from multiple cases of sporadic and inherited Alzheimer\u2019s disease adopt a common fold. Acta Neuropathol. 136, 699\u2013708 (2018).","journal-title":"Acta Neuropathol."},{"key":"32951_CR22","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1021\/mp4000794","volume":"10","author":"AJ Smith","year":"2013","unstructured":"Smith, A. J. et al. Crystal engineering of green tea epigallocatechin-3-gallate (EGCg) cocrystals and pharmacokinetic modulation in rats. Mol. Pharm. 10, 2948\u20132961 (2013).","journal-title":"Mol. Pharm."},{"key":"32951_CR23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J. Comput. Chem. 31, 455 (2010).","journal-title":"J. Comput. Chem."},{"key":"32951_CR24","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/prot.21086","volume":"65","author":"J Meiler","year":"2006","unstructured":"Meiler, J. & Baker, D. ROSETTALIGAND: protein-small molecule docking with full side-chain flexibility. Proteins 65, 538\u2013548 (2006).","journal-title":"Proteins"},{"key":"32951_CR25","first-page":"E4376","volume":"111","author":"BB Holmes","year":"2014","unstructured":"Holmes, B. B. et al. Proteopathic tau seeding predicts tauopathy in vivo. Proc. Natl Acad. Sci. USA 111, E4376\u2013E4385 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32951_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13024-020-00389-1","volume":"15","author":"S Kaniyappan","year":"2020","unstructured":"Kaniyappan, S. et al. FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments. Mol. Neurodegener. 15, 39 (2020).","journal-title":"Mol. Neurodegener."},{"key":"32951_CR27","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00401-021-02294-3","volume":"141","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Cryo-EM structures of tau filaments from Alzheimer\u2019s disease with PET ligand APN-1607. Acta Neuropathol. 141, 697\u2013708 (2021).","journal-title":"Acta Neuropathol."},{"key":"32951_CR28","doi-asserted-by":"publisher","first-page":"13853","DOI":"10.1523\/JNEUROSCI.2600-15.2015","volume":"35","author":"I Lindberg","year":"2015","unstructured":"Lindberg, I. et al. Chaperones in Neurodegeneration. J. Neurosci. 35, 13853\u201313859 (2015).","journal-title":"J. Neurosci."},{"key":"32951_CR29","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41418-020-00706-7","volume":"28","author":"MF Schmidt","year":"2021","unstructured":"Schmidt, M. F., Gan, Z. Y., Komander, D. & Dewson, G. Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities. Cell Death Differ. 28, 570\u2013590 (2021).","journal-title":"Cell Death Differ."},{"key":"32951_CR30","doi-asserted-by":"publisher","first-page":"9676","DOI":"10.1074\/jbc.RA120.013478","volume":"295","author":"E Nachman","year":"2020","unstructured":"Nachman, E. et al. Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species. J. Biol. Chem. 295, 9676 (2020).","journal-title":"J. Biol. Chem."},{"key":"32951_CR31","doi-asserted-by":"publisher","unstructured":"Saha, I. et al. The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds. 2022.02.18.481043 Preprint at https:\/\/doi.org\/10.1101\/2022.02.18.481043 (2022).","DOI":"10.1101\/2022.02.18.481043"},{"key":"32951_CR32","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41586-019-1026-5","volume":"568","author":"B Falcon","year":"2019","unstructured":"Falcon, B. et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature 568, 420\u2013423 (2019).","journal-title":"Nature"},{"key":"32951_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tibs.2007.03.003","volume":"32","author":"DM Fowler","year":"2007","unstructured":"Fowler, D. M., Koulov, A. V., Balch, W. E. & Kelly, J. W. Functional amyloid\u2212from bacteria to humans. Trends Biochem. Sci. 32, 217\u2013224 (2007).","journal-title":"Trends Biochem. Sci."},{"key":"32951_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/pro.3967","volume":"30","author":"A Cheng","year":"2021","unstructured":"Cheng, A. et al. Leginon: new features and applications. Protein Sci. Publ. Protein Soc. 30, 136\u2013150 (2021).","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"32951_CR35","doi-asserted-by":"publisher","first-page":"e06980","DOI":"10.7554\/eLife.06980","volume":"4","author":"T Grant","year":"2015","unstructured":"Grant, T. & Grigorieff, N. Measuring the optimal exposure for single particle cryo-EM using a 2.6 \u00c5 reconstruction of rotavirus VP6. eLife 4, e06980 (2015).","journal-title":"eLife"},{"key":"32951_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"32951_CR37","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jsb.2015.08.006","volume":"192","author":"T Grant","year":"2015","unstructured":"Grant, T. & Grigorieff, N. Automatic estimation and correction of anisotropic magnification distortion in electron microscopes. J. Struct. Biol. 192, 204\u2013208 (2015).","journal-title":"J. Struct. Biol."},{"key":"32951_CR38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","volume":"157","author":"G Tang","year":"2007","unstructured":"Tang, G. et al. EMAN2: an extensible image processing suite for electron microscopy. J. Struct. Biol. 157, 38\u201346 (2007).","journal-title":"J. Struct. Biol."},{"key":"32951_CR39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SHW Scheres","year":"2012","unstructured":"Scheres, S. H. W. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519\u2013530 (2012).","journal-title":"J. Struct. Biol."},{"key":"32951_CR40","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1107\/S2059798318004655","volume":"74","author":"TC Terwilliger","year":"2018","unstructured":"Terwilliger, T. C., Sobolev, O. V., Afonine, P. V. & Adams, P. D. Automated map sharpening by maximization of detail and connectivity. Acta Crystallogr. Sect. Struct. Biol. 74, 545\u2013559 (2018).","journal-title":"Acta Crystallogr. Sect. Struct. Biol."},{"key":"32951_CR41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"32951_CR42","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. Sect. Struct. Biol. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. Sect. Struct. Biol."},{"key":"32951_CR43","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1016\/j.cell.2021.08.013","volume":"184","author":"MR Sawaya","year":"2021","unstructured":"Sawaya, M. R., Hughes, M. P., Rodriguez, J. A., Riek, R. & Eisenberg, D. S. The expanding amyloid family: Structure, stability, function, and pathogenesis. Cell 184, 4857\u20134873 (2021).","journal-title":"Cell"},{"key":"32951_CR44","first-page":"217","volume":"29","author":"D Eisenberg","year":"1989","unstructured":"Eisenberg, D., Wesson, M. & Yamashita, M. Interpretation of protein folding and binding with atomic solvation parameters. Chem. Scr. 29, 217\u2013222 (1989).","journal-title":"Chem. Scr."},{"key":"32951_CR45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1006\/jmbi.1994.1366","volume":"239","author":"P Koehl","year":"1994","unstructured":"Koehl, P. & Delarue, M. Application of a self-consistent mean field theory to predict protein side-chains conformation and estimate their conformational entropy. J. Mol. Biol. 239, 249\u2013275 (1994).","journal-title":"J. Mol. Biol."},{"key":"32951_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open Babel: an open chemical toolbox. J. Cheminformatics 3, 33 (2011).","journal-title":"J. Cheminformatics"},{"key":"32951_CR47","doi-asserted-by":"crossref","unstructured":"Jiang, L. et al. Structure-based discovery of fiber-binding compounds that reduce the cytotoxicity of amyloid beta. eLife 2, e00857 (2013).","DOI":"10.7554\/eLife.00857"},{"key":"32951_CR48","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel, D. et al. GROMACS: fast, flexible, and free. J. Comput. Chem. 26, 1701\u20131718 (2005).","journal-title":"J. Comput. Chem."},{"key":"32951_CR49","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","volume":"31","author":"K Vanommeslaeghe","year":"2010","unstructured":"Vanommeslaeghe, K. et al. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31, 671\u2013690 (2010).","journal-title":"J. Comput. Chem."},{"key":"32951_CR50","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32951-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32951-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32951-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T21:34:58Z","timestamp":1701034498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32951-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["32951"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-32951-4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742323115.793597078","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"assertion":[{"value":"26 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.S.E. is SAB chair and equity holder of ADRx, Inc. All other authors declare no conflicts.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5451"}}